| Prev Close: | 72.97 |
|---|---|
| Open: | 72.79 |
| Bid: | 72.62 x 800 |
| Ask: | 72.70 x 200 |
| NAV¹: | 71.35 |
| Net Assets²: | 220.34M |
| YTD Return (Mkt)²: | 21.50% |
| Day's Range: | 72.32 - 72.79 |
|---|---|
| 52wk Range: | 43.77 - 75.44 |
| Volume: | 6,121 |
| Avg Vol (3m): | 116,197 |
| P/E (ttm)²: | 22 |
| Yield (ttm)²: |
¹As of Apr 21, 2013
²As of Mar 30, 2013
Headlines
- A Trio of ETFs Sitting on 30% Gains This YearETF Trends(Thu, May 23)
- Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rallyat Investor's Business Daily(Wed, May 22)
- Biotech ETF Rallies Over 30% as Cash Tumbles InETF Trends(Wed, May 22)
- [video] Bioterrorism Profitsat CNBC(Mon, May 20)
- [video] Faber Report: Royalty Pharma to Raise Elan Bidat CNBC(Mon, May 20)
- Biotechnology ETF Investing 101Zacks(Mon, May 20)
- A Journey To Add Biotech To The Portfolioat Seeking Alpha(Sat, May 18)
- [video] What's Working in Pharmaat CNBC(Mon, May 13)
- Best ETFs In 2013: DBJP, Tesla-Fueled QCLNIndexUniverse.com(Mon, May 13)
- 7 ETFs Up More Than 10% This Earnings SeasonETF Database(Fri, May 10)
- [video] Perrigo CEO: Mucinex Product Will Be a Big Winnerat CNBC(Thu, May 9)
- Investors Clamor for Generic Drug ETFETF Trends(Mon, May 6)
- [video] No Huddle Offense: What's Working In Pharmaat CNBC(Fri, May 3)
- [video] You Ask, Cramer Answers! Buy Trius?at CNBC(Fri, May 3)
- [video] Charles River CEO: Had a Negligible Impact From Sequesterat CNBC(Thu, May 2)
Reports
- BBH: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(May 24)
- BIOTECH HOLDERS TR (BBH) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)
- BIOTECH HOLDERS TR (BBH) 12-months forecastPechala's Reports(May 18)
